blgo_8k-062512.htm
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 
FORM 8-K
 
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported): June 25, 2012
 
 
BioLargo, Inc.
(Exact name of registrant as specified in its charter)
 
 
 
Delaware
  
000-19709
  
65-0159115
(State or other jurisdiction
of incorporation)
  
(Commission File Number)
  
(IRS Employer
Identification No.)
 

16150 Heron Avenue, La Mirada, CA
  
90638
(Address of principal executive offices)
  
(Zip Code)
 
Registrant’s telephone number, including area code: (949) 643-9540
 
(Former name or former address, if changed since last report)
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17CFR 240.14d-2(b))
 
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17CFR 240.13e-4(c))
 
 
 
 
 
Item 5.07           Submission of Matters to a Vote of Security Holders
 
BioLargo, Inc. (the “Company”) held its 2012 annual stockholder meeting on June 25, 2012.  The following matters were each submitted to a vote of stockholders through the solicitation of proxies or otherwise:
 
(1) Election of directors – Seven individuals were each elected to our board of directors.
 
(2) Ratification of appointment of accounting firm – Appointment of Haskell & White, LLP by our board’s Audit Committee as the Company’s independent registered public accounting firm was ratified.
 
The voting results from the annual meeting on the election of directors and ratification of appointment of accounting firm are as follows:
 
Item
Nominee:
  
Votes For
  
Votes Against
  
Votes Withheld
  
Abstentions
  
Broker Non Vote
  
Election of Directors
                      
 
Dennis P. Calvert
   33,046,805    -   9,400    -   8,939,735  
 
Kenneth R. Code
   33,053,613    -   2,592    -   8,939,735  
 
Joseph L. Provenzano
   33,053,613    -   2,592    -   8,939,735  
 
Dennis E. Marshall
   33,046,845    -   9,360    -   8,939,735  
 
Gary A. Cox
   33,053,653    -   2,552    -   8,939,735  
 
Kent C. Roberts II
   33,053,653    -   2,552    -   8,939,735  
 
John S. Runyan
   33,053,653    -   2,552    -   8,939,735  
Ratification of Accounting Firm
   41,880,488  
200
   128,572  
128,572
   -  

 
There were no director nominees other than as set forth above.
 

 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
Date: June 27, 2012
BIOLARGO, INC.
  
       
 
By:
/s/ Dennis P. Calvert
  
   
Dennis P. Calvert
  
   
President and Chief Executive Officer